SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Jefferies Downgrades Supernus Pharmaceuticals to Hold

Jefferies downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) from Buy to Hold.

Benzinga · -

Jefferies downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) from Buy to Hold.